Smith+Nephew Archives - Page 6 of 6 - Medical Design Sourcing

Smith+Nephew, Hall of Fame Health to partner on former NFL players’ wellness

Smith+Nephew (NYSE:SNN) announced that it entered into a partnership to deploy its digital health portfolio for former NFL players.

London-based Smith+Nephew’s partnership with Hall of Fame Health is slated to see the latter join surgeons and facilities across the U.S. to certify certain locations as “centers of excellence” and ensure Smith+Nephew’s care is available to all communities nationwide.

The partnership is designed to supplement other healthcare options for the ex-players who are seeking joint replacement through a quality care network, including those that the NFL and its Player Care Foundation offers.

“From the beginning, our mission has been to provide world-class services to former NFL players and their families and to do so in a way where the programs we build can have a greater impact across our communities,” Hall of Fame Health CEO Jeremy Hogue said in a news release. “Our partnership with Smith+Neph…

Smith+Nephew sees Movemedical automating inventory for its sales people

Smith+Nephew (NYSE:SNN) announced today that it has successfully introduced a new field sales operations and inventory automation system in the U.S. in partnership with Movemedical.

The new system is meant to help field sales reps better manage their daily inventory operations — and better serve surgeons’ needs — boosting automation and transparency.

Real-time data will enable smooth matching of customer requirements and product availability, according to S+N.

“The Movemedical solution will help ensure that the right product gets to the right customer – and the right patient – through the provision of clean and accurate data in real-time, empowering our teams to make faster and better decisions,” said Skip Kiil, global president of orthopedics at Smith+Nephew.

“We were able to roll out the program to our entire U.S. Orthopaedic sales force in just over one week, and in the middle of a very busy selling period. This undersc…

Smith + Nephew closes Extremity Orthopedics purchase

Integra LifeSciences (NSDQ:IART) announced today that it completed the divestiture of its extremity orthopedics business to Smith+Nephew (NYSE:SNN).

The companies previously announced the planned divestiture, worth $240 million, in September 2020.

At the time, London-based Smith+Nephew said that the acquisition would significantly strengthen its extremities business by adding a combination of a focused sales channel and complimentary shoulder replacement and upper and lower extremities portfolios, plus a new product pipeline.

Integra’s commercial sales force to be inherited by Smith+Nephew focuses predominantly in the U.S. with further sales and distribution in Canada and Europe.

The inherited portfolio includes devices, implants and instruments designed for shoulder replacement and reconstruction of bone in the hand, wrist and elbow, along with the foot and ankle. Additionally, the pipeline includes a next-generation shoulder replacement system e…

The top 5 medtech CEO quotes about COVID-19

The latest earnings season not only provided insights from top medtech CEOs about how the COVID-19 pandemic is changing the industry, but also lessons learned going forward.

Here are five top quotes about lessons learned.

Next>>

DeviceTalks editorial director Tom Salemi contributed to this report.

The top 5 medtech CEO quotes about COVID-19

The latest earnings season not only provided insights from top medtech CEOs about how the COVID-19 pandemic is changing the industry, but also lessons learned going forward.

Here are five top quotes about lessons learned.

Next>>

DeviceTalks editorial director Tom Salemi contributed to this report.

The top 5 MassDevice stories of the week — July 31, 2020

The past week has seen a slew of Q2 earnings reports from medical device companies — and the picture overall hasn’t been pretty amid the COVID-19 pandemic.

Still, medtech CEOs during their earnings calls said they’re starting to see some signs of hospital procedures recovering a bit even as the southern U.S. deals with a coronavirus wave. Some of the top MassDevice stories this week actually involved companies providing more solutions to improve management of the pandemic.

Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five:

5. A few bright spots amid the COVID-19 financial toll

Dexcom (NSDQ:DXCM) proved to be one of the few bright spots among medtech Q2 earnings reports, blowing away the Wall Street consensus forecast as it successfully pivoted to making its continuous glucose monitors avail…

Smith+Nephew misses expectations in Q2

Smith+Nephew (LON:SN) today reported Q2 results that missed the consensus forecast of analysts as the COVID-19 pandemic drove revenue down nearly 30%, to $901 million.

The British orthopedics, sports medicine and wound care products company, however, also reported that it saw elective procedures resume across the U.S. and much of Europe by the time the quarter ended on June 27 — a positive sign for the rest of the year.

Trading profit for the first half of the year — the company’s preferred metric that excludes one-time items — was $172 million, down 68% from the first half of 2019.

Analyst predictions compiled by the company on average expected a trading profit of $225 million for the first half of the year, with the company bringing in $905 million in revenue in Q2.

Smith+Nephew CEO Roland Diggelmann said the company has sought to emerge from the pandemic crisis as strong as possible, maintaining its R&D spend, launching new products, …

Smith+Nephew launches next-gen surgical robotics system

The Cori surgical system [Image courtesy of Smith+Nephew]

Competition continues to heat up in the robotic orthopedic surgery space, with Smith+Nephew (LON:SN) today announcing the launch of its next-gen Cori surgical system.

Cleared by FDA and available for both total and unicompartmental knee arthroplasty, the handheld Cori robotics platform is meant to be faster than S+N’s previous Navio system. On top of Cori, the British medtech giant is also launching its Real Intelligence suite of digital surgery solutions that are meant to improve patient engagement, pre-operative planning, digital and robotic surgery, post-operative assessment and outcomes measurement.

“The Real Intelligence brand is a statement of how Smith+Nephew thinks, innovates,and reimagines surgery,” said Skip Kiil, president of Orthopaedics for Smith+Nephew.

“The introduction of the Cori surgical system’…